Steve Brozak

Stock Analyst at WBB Securities

(0.44)
# 3,999
Out of 4,876 analysts
8
Total ratings
30%
Success rate
-16.43%
Average return

Stocks Rated by Steve Brozak

Cidara Therapeutics
Jun 23, 2025
Reiterates: Strong Buy
Price Target: $45
Current: $49.45
Upside: -9.00%
Marker Therapeutics
Apr 1, 2025
Reiterates: Strong Buy
Price Target: $13
Current: $1.47
Upside: +750.34%
Omeros
Jun 18, 2021
Maintains: Strong Buy
Price Target: $75$100
Current: $3.20
Upside: +3,025.00%
RedHill Biopharma
May 28, 2021
Downgrades: Buy
Price Target: $17,000$16,000
Current: $1.85
Upside: +863,644.33%